LLY

988.57

+2.13%↑

JNJ

225.57

+0.63%↑

UNH

363.82

-1.87%↓

MRK

113.2

+0.05%↑

NVS

145.46

+0.64%↑

LLY

988.57

+2.13%↑

JNJ

225.57

+0.63%↑

UNH

363.82

-1.87%↓

MRK

113.2

+0.05%↑

NVS

145.46

+0.64%↑

LLY

988.57

+2.13%↑

JNJ

225.57

+0.63%↑

UNH

363.82

-1.87%↓

MRK

113.2

+0.05%↑

NVS

145.46

+0.64%↑

LLY

988.57

+2.13%↑

JNJ

225.57

+0.63%↑

UNH

363.82

-1.87%↓

MRK

113.2

+0.05%↑

NVS

145.46

+0.64%↑

LLY

988.57

+2.13%↑

JNJ

225.57

+0.63%↑

UNH

363.82

-1.87%↓

MRK

113.2

+0.05%↑

NVS

145.46

+0.64%↑

Home・Akciju saraksts・Intuitive Surgical Inc

Intuitive Surgical Inc

Slēgts

SektorsVeselības aprūpe

451.55 -0.21

Pirkt Pārdot

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

441.95

Max

458.13

Galvenie mērījumi
By Trading Economics
Ienākumi	22M 822M
Pārdošana	-95M 2.8B
P/E Sektora vidējais	55.571 67.147
EPS	2.5
Peļņas marža	29.648
Darbinieki	17,021
EBITDA	-230M 855M

Rekomendācijas
By TipRanks
Rekomendācijas	Pirkt
Prognoze 12 mēnešiem	+27.45% upside

Dividendes
By Dow Jones
Nākamie ieņēmumi	2026. g. 21. jūl.

Tirgus statistika
By TradingEconomics
Tirgus kapitalizācija	-5.2B 160B
Iepriekšējā atvēršanas cena	451.76
Iepriekšējā slēgšanas cena	451.55

Ziņu noskaņojums

By Acuity

18%

82%

46 / 347 Rangs Healthcare

Tehniskais rādītājs

By Trading Central

Pārliecība

Weak Bearish Evidence

514.59 / 539.05 Atbalsts un pretestība

Intuitive Surgical Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 22. apr. 15:47 UTC

Galvenie tirgus virzītāji

Intuitive Surgical Shares Rise After 1Q Beat

2026. g. 21. apr. 20:54 UTC

Peļņas

Intuitive Surgical Posts Higher 1Q Sales, Profit

2026. g. 22. apr. 11:27 UTC

Peļņas

Intuitive Surgical Earnings Show Big Beats Don't Always Spark Stock Rallies -- Barrons.com

2026. g. 21. apr. 21:14 UTC

Peļņas

Intuitive Surgical Earnings Show Big Beats Don't Always Spark Stock Rallies -- Barrons.com

2026. g. 21. apr. 20:38 UTC

Peļņas

Intuitive Surgical 1Q Rev $2.77B >ISRG

2026. g. 21. apr. 20:38 UTC

Peļņas

Intuitive Surgical 1Q Net $821.5M >ISRG

2026. g. 21. apr. 20:38 UTC

Peļņas

Intuitive Surgical 1Q Da Vinci Surgical Systems Shipped 431.00 >ISRG

2026. g. 21. apr. 20:38 UTC

Peļņas

Intuitive Surgical 1Q Adj EPS $2.50 >ISRG

2026. g. 21. apr. 20:38 UTC

Peļņas

Intuitive Surgical 1Q EPS $2.28 >ISRG

2026. g. 21. apr. 20:14 UTC

Peļņas

Intuitive Surgical Sees 2026 Worldwide Da Vinci Procedure Growth of About 13.5% to 15.5%

2026. g. 21. apr. 20:14 UTC

Peļņas

Intuitive Surgical 1Q Rev $2.77B

2026. g. 21. apr. 20:13 UTC

Peļņas

Intuitive Surgical 1Q Adj EPS $2.50

2026. g. 21. apr. 20:12 UTC

Peļņas

Intuitive Surgical 1Q EPS $2.28

2026. g. 14. apr. 14:13 UTC

Peļņas

Johnson & Johnson Financial Chief Sees 'Clear Line of Sight' to Double-Digit Growth by 2030 -- Barrons.com

2026. g. 14. apr. 12:57 UTC

Peļņas

Johnson & Johnson Financial Chief Sees 'Clear Line of Sight' to Double-Digit Growth by 2030 -- Barrons.com

2026. g. 17. febr. 14:48 UTC

Peļņas

Medtronic Posts Better-Than-Expected Earnings. Here's Why the Stock Is Falling. -- Barrons.com

2026. g. 23. janv. 16:07 UTC

Peļņas

Intuitive Surgical Stock Beats Earnings Estimates. The Stock Is Barely Moving. -- Barrons.com

2026. g. 23. janv. 12:58 UTC

Peļņas

Intuitive Surgical Stock Rises on Earnings. What Wall Street Is Saying. -- Barrons.com

2026. g. 22. janv. 21:11 UTC

Peļņas

Intuitive Surgical Sees 2026 Impact From Tariffs 1.2% of Revenue, Plus or Minus 10 Basis Points >ISRG

2026. g. 22. janv. 21:11 UTC

Peļņas

Intuitive Surgical Sees 2026 Adjusted Gross Profit Margin 67%-68% >ISRG

2026. g. 22. janv. 21:10 UTC

Peļņas

Intuitive Surgical Sees 2026 Worldwide Da Vinci Procedure Growth of 13%-15% >ISRG

2026. g. 22. janv. 21:05 UTC

Peļņas

Intuitive Surgical 4Q EPS $2.21 >ISRG

2026. g. 22. janv. 21:05 UTC

Peļņas

Intuitive Surgical 4Q Rev $2.87B >ISRG

2026. g. 22. janv. 21:05 UTC

Peļņas

Intuitive Surgical 4Q Net $794.8M >ISRG

2026. g. 22. janv. 21:05 UTC

Peļņas

Intuitive Surgical 4Q Adj EPS $2.53 >ISRG

2026. g. 22. janv. 21:05 UTC

Peļņas

Intuitive Surgical 4Q Da Vinci Surgical Systems Shipped 532.00 >ISRG

2025. g. 30. okt. 12:38 UTC

Peļņas

Looking to Diversify Out of the AI Trade? Buy Boston Scientific Stock. -- Barrons.com

2025. g. 30. okt. 12:01 UTC

Peļņas

Looking to Diversify Out of the AI Trade? Buy Boston Scientific Stock. -- Barrons.com

2025. g. 22. okt. 15:42 UTC

Peļņas

Intuitive Surgical Stock Jumps on Earnings. Its Newest Surgical Robot Is Going Gangbusters. -- Barrons.com

2025. g. 22. okt. 12:34 UTC

Peļņas

Intuitive Surgical Stock Surges. Earnings Show It Can Maintain 'Bellwether Medtech Growth Status.' -- Barrons.com

Salīdzinājums

Cenas izmaiņa

Intuitive Surgical Inc Prognoze

Cenas mērķis

By TipRanks

27.45% augšup

Prognoze 12 mēnešiem

Vidējais 576.53 USD 27.45%

Augstākais 670 USD

Zemākais 451 USD

Pamatojoties uz 20 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Intuitive Surgical Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt

20 ratings

Pirkt

Turēt

Pārdot

Pamatojoties uz 20 analītiķiem, kas pēdējo 3 mēnešu laikā snieguši akciju vērtējumus instrumentam Intuitive Surgical Inc — pēdējo 3 mēnešu laikā.

Tehniskais rādītājs

By Trading Central

514.59 / 539.05Atbalsts un pretestība

Recent bearish events outweigh bullish events.

Recent bullish events outweigh bearish events.

All events are bullish.

Noskaņojums

By Acuity

46 / 347 Rangs Veselības aprūpe

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

Par Intuitive Surgical Inc

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.